[ Price : $8.95]
FDA approves a Neuralstem, Inc. IND to begin a Phase 1a safety trial of NSI-189 in major depression.[ Price : $8.95]
The investigative journalism Web site Fairwarning criticizes FDA and Pfizer for not initially testing Chantix on patients with men...[ Price : $8.95]
FDA clears an Accuray Inc. 510(k) for its Lung Optimized Treatment, a new component for the firm's CyberKnife VSI System for perfo...[ Price : $8.95]
Orion Corp. considers a patent infringement suit against Mylan after being told the company has submitted an ANDA for a generic co...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on the co-development of two or more unmarketed investigational drugs for u...[ Price : $8.95]
Federal Register Notice: FDA adds two new offices to its Center for Tobacco Products.[ Price : $8.95]
FDAs Medical Devices Advisory Committee hears a wide variety of views regarding the safety and classification of dental amalgam.[ Price : $8.95]
CDERs Drug Safety Oversight Board says it discussed a concern involving benzocaine and methemglobinemia at its 11/18 meeting.